{"id":5350,"date":"2016-08-17T19:50:43","date_gmt":"2016-08-17T19:50:43","guid":{"rendered":"https:\/\/lmcca.wpengine.com\/?p=5350"},"modified":"2016-08-17T19:56:02","modified_gmt":"2016-08-17T19:56:02","slug":"sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes","status":"publish","type":"post","link":"https:\/\/www.lmc.ca\/zh\/news\/sanofi-receives-fda-approval-adlyxintm-treatment-adults-type-2-diabetes\/","title":{"rendered":"\u8d5b\u8bfa\u83f2\u7684 AdlyxinTM \u83b7\u5f97 FDA \u6279\u51c6\u7528\u4e8e\u6cbb\u7597\u6210\u4eba 2 \u578b\u7cd6\u5c3f\u75c5\u60a3\u8005"},"content":{"rendered":"<p><a href=\"http:\/\/en.sanofi.com\/\">\u8d5b\u8bfa\u83f2<\/a> \u4e8e7\u670828\u65e5\u5ba3\u5e03\uff0c\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u6279\u51c6\u4e86Adlyxin<sup>\u6709\u9650\u516c\u53f8<\/sup> \u5229\u897f\u62c9\u6765\uff08lixisenatide\uff09\uff0c\u4e00\u79cd\u6bcf\u65e5\u4e00\u6b21\u7684\u9910\u65f6GLP-1\u53d7\u4f53\u6fc0\u52a8\u5242\u6ce8\u5c04\u5242\uff0c\u7528\u4e8e\u996e\u98df\u548c\u8fd0\u52a8\u7684\u8f85\u52a9\u6cbb\u7597\uff0c\u9002\u7528\u4e8e2\u578b\u7cd6\u5c3f\u75c5\u6210\u5e74\u60a3\u8005\u3002.<\/p>\n<p><em>\u201cAdlyxin \u7684\u83b7\u6279\u91cd\u7533\u4e86\u6211\u4eec\u81f4\u529b\u4e8e\u89e3\u51b3\u7cd6\u5c3f\u75c5\u60a3\u8005\u5728\u8fbe\u5230\u548c\u7ef4\u6301\u4e2a\u4f53\u8840\u7cd6\uff08HbA1c\uff09\u76ee\u6807\u65f6\u9762\u4e34\u7684\u6311\u6218\u3002\u201d<\/em> \u8d5b\u8bfa\u83f2\u5168\u7403\u7cd6\u5c3f\u75c5\u4e0e\u5fc3\u8840\u7ba1\u4e1a\u52a1\u90e8\u95e8\u6267\u884c\u526f\u603b\u88c1\u517c\u8d1f\u8d23\u4eba Peter Guenter\n\u8868\u793a\uff1a\u201c\u6211\u4eec\u5bf9\u8fd9\u9879\u6279\u51c6\u611f\u5230\u9ad8\u5174\uff0c\u56e0\u4e3a\u5b83\u4e3a\u6211\u4eec\u63d0\u4f9b\u4e86\u7ee7\u7eed\u5e2e\u52a9\u672a\u5f97\u5230\u6709\u6548\u63a7\u5236\u7684\u63a5\u53d7\u57fa\u7840\u80f0\u5c9b\u7d20\u6cbb\u7597\u7684\u60a3\u8005\u7684\u673a\u4f1a\u3002\u201d.<\/p>\n<p>Adlyxin \u7684\u6279\u51c6<sup>\u6709\u9650\u516c\u53f8<\/sup> \u57fa\u4e8eFDA\u5bf9GetGoal\u4e34\u5e8a\u9879\u76ee\u7ed3\u679c\u548cELIXA\u8bd5\u9a8c\u7ed3\u679c\u7684\u5ba1\u67e5\uff0c\u8be5\u8bd5\u9a8c\u6210\u529f\u6ee1\u8db3\u4e86FDA\u5173\u4e8e\u8bc1\u660e\u5fc3\u8840\u7ba1\u5b89\u5168\u6027\u7684\u8981\u6c42\u3002GetGoal\u4e34\u5e8a\u9879\u76ee\u5305\u62ec13\u9879\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u6d89\u53ca\u5168\u74035000\u591a\u540d2\u578b\u7cd6\u5c3f\u75c5\u6210\u4eba\u60a3\u8005\uff0c\u8bc4\u4f30\u4e86\u5229\u897f\u90a3\u80bd\u57282\u578b\u7cd6\u5c3f\u75c5\u6210\u4eba\u60a3\u8005\u4e2d\u7684\u5b89\u5168\u6027\u548c\u6709\u6548\u6027\u3002GetGoal\u9879\u76ee\u7684\u6240\u6709\u7814\u7a76\u5747\u6210\u529f\u8fbe\u5230\u4e86\u964d\u4f4e\u7cd6\u5316\u8840\u7ea2\u86cb\u767d\uff08HbA1c\uff09\u7684\u4e3b\u8981\u7597\u6548\u7ec8\u70b9\u3002Adlyxin\u62a5\u544a\u4e2d\u6700\u5e38\u89c1\u7684\u4e0d\u826f\u4e8b\u4ef6\u5305\u62ec\u6076\u5fc3\u3001\u4f4e\u8840\u7cd6\u548c\u5455\u5410\u3002.<\/p>\n<p>Adlyxin \u5c06\u4ee5\u4e00\u6b21\u6027\u9884\u586b\u5145\u6ce8\u5c04\u7b14\u7684\u5f62\u5f0f\u63d0\u4f9b\uff0c\u5355\u5242\u91cf\u4e3a 20 \u5fae\u514b\u3002\u60a3\u8005\u8fd8\u5c06\u6536\u5230\u4e00\u652f\u5355\u5242\u91cf\u4e3a 10 \u5fae\u514b\u7684\u9884\u586b\u5145\u6ce8\u5c04\u7b14\uff0c\u5e94\u6bcf\u5929\u6ce8\u5c04\u4e00\u6b21\uff0c\u6301\u7eed 14 \u5929\u3002\u7b2c 15 \u5929\uff0c\u60a3\u8005\u5c06\u5242\u91cf\u589e\u52a0\u5230\u6bcf\u5929 20 \u5fae\u514b\uff0c\u6bcf\u5929\u6ce8\u5c04\u4e00\u6b21\u3002.<\/p>\n<p>\u5982\u9700\u67e5\u770b\u5168\u6587\uff0c\u8bf7\u70b9\u51fb<a href=\"http:\/\/www.europeanpharmaceuticalreview.com\/42672\/news\/industry-news\/adlyxin-sanofi-fda-approval-type-2-diabetes\/\"> \u8fd9\u91cc<\/a><\/p>\n<h3 style=\"text-align: center;\"><a href=\"https:\/\/www.lmc.ca\/zh\/\">LMC \u7cd6\u5c3f\u75c5\u4e0e\u5185\u5206\u6ccc\u79d1<\/a> \u5f88\u8363\u5e78\u53c2\u4e0e\u4e86\u8fd9\u4e9b\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u5e76\u6210\u4e3aAdlyxin\u6279\u51c6\u8fc7\u7a0b\u7684\u4e00\u90e8\u5206\u3002<sup>\u6709\u9650\u516c\u53f8<\/sup> \u5229\u897f\u62c9\u6765\u5728\u6211\u4eec\u7684\u52a0\u62ff\u5927\u8bca\u6240\u3002\u4e34\u5e8a\u7814\u7a76\u662f\u836f\u7269\u5ba1\u6279\u8fc7\u7a0b\u4e2d\u4e0d\u53ef\u6216\u7f3a\u7684\u4e00\u90e8\u5206\u2014\u2014\u5982\u679c\u6ca1\u6709\u50cf\u60a8\u8fd9\u6837\u7684\u4eba\uff0c\u8fd9\u4e9b\u836f\u7269\u5c06\u65e0\u6cd5\u83b7\u5f97\u6279\u51c6\uff0c\u751a\u81f3\u4e0d\u53ef\u80fd\u5b58\u5728\uff01<\/h3>\n<h3 style=\"text-align: center;\">\u611f\u8c22\u60a8\u4e3a\u7814\u7a76\u6240\u505a\u7684\u4e00\u5207\uff01<\/h3>\n<p>&nbsp;<\/p>\n<h3 style=\"text-align: center;\"><em>\u6709\u5174\u8da3\u53c2\u52a0\u672a\u6765\u7684 2 \u578b\u7cd6\u5c3f\u75c5\u7814\u7a76\u5417\uff1f<br \/>\n\u8bbf\u95ee <a href=\"http:\/\/www.improvinghealth.ca\">www.improvinghealth.ca\u00a0<\/a>\u4e86\u89e3\u66f4\u591a\u5173\u4e8e <a href=\"http:\/\/improvinghealth.ca\/studies\/\">\u6b63\u5728\u8fdb\u884c\u7684\u6d3b\u52a8<\/a> \u6211\u4eec\u6b63\u5728\u62db\u8058\uff01\u00a0<\/em><\/h3>","protected":false},"excerpt":{"rendered":"<p>Sanofi announced on July 28th that the U.S. Food and Drug Administration (FDA) approved AdlyxinTM (lixisenatide), a once-daily mealtime GLP-1 receptor agonist injection indicated as an adjunct to diet and exercise for the treatment of adults with type 2 diabetes. \u201cThe approval of Adlyxin reaffirms our continued commitment to addressing the challenges faced by people [&hellip;]<\/p>\n","protected":false},"author":25,"featured_media":5352,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","two_page_speed":[],"footnotes":""},"categories":[163],"tags":[156,155,83,112,161,160,159,124,162,154,158,157],"class_list":["post-5350","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-adlyxin","tag-adlyxintm","tag-diabetes-research","tag-diabetes-specialists","tag-elixa-trial","tag-getgoal","tag-getgoal-clinical-program","tag-lmc-diabetes","tag-lmc-diabetes-endocrinology","tag-sanofi","tag-t2-diabetes","tag-type-2-diabetes"],"_links":{"self":[{"href":"https:\/\/www.lmc.ca\/zh\/wp-json\/wp\/v2\/posts\/5350","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lmc.ca\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.lmc.ca\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.lmc.ca\/zh\/wp-json\/wp\/v2\/users\/25"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lmc.ca\/zh\/wp-json\/wp\/v2\/comments?post=5350"}],"version-history":[{"count":0,"href":"https:\/\/www.lmc.ca\/zh\/wp-json\/wp\/v2\/posts\/5350\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.lmc.ca\/zh\/wp-json\/wp\/v2\/media\/5352"}],"wp:attachment":[{"href":"https:\/\/www.lmc.ca\/zh\/wp-json\/wp\/v2\/media?parent=5350"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.lmc.ca\/zh\/wp-json\/wp\/v2\/categories?post=5350"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.lmc.ca\/zh\/wp-json\/wp\/v2\/tags?post=5350"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}